Kenneth Kulmatycki

ORCID: 0000-0003-2002-3966

Also affiliated with Novartis (United States), Novartis Institutes for BioMedical Research

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial”.

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial

International Journal of COPD(2020)10.2147/copd.s257474

N/A

0DataRank · unranked

62 citations

Ieuan Jones, Mark T. Dransfield, Nazmul Haque, Stephen Gleason, Katy Hayes +7 more